Sponsor pipeline

Epygenix clinical trial pipeline

Get alerts when Epygenix's trials change

2 active trials 2 recruiting 2 Phase 3 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-16
Trial sites expanded: 55 → 58 locations
NCT05066217 An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome · Phase 3
2026-08-22
Trial sites expanded: 26 → 55 locations
NCT05066217 An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome · Phase 3

Active trials by phase

Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04462770 A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome Dravet Syndrome Recruiting 2026-09-15
NCT05066217 An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome Lennox Gastaut Syndrome Recruiting 2026-09-15

Disease areas by active trials

Epilepsy (2)

Get alerts when Epygenix's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free